Optical technologies and molecular imaging for cervical neoplasia: A program project update

Timon P.H. Buys; Scott B. Cantor; Martial Guillaud; Karen Adler-Storthz; Dennis D. Cox; Clement Okolo; Oyedunni Arulogon; Oladimeji Oladepo; Karen Basen-Engquist; Eileen Shinn; Jos Miguel Yamal; J. Robert Beck; Michael E. Scheurer; Dirk Van Niekerk; Anais Malpica; Jasenka Matisic; Gregg Staerkel; Edward Neely Atkinson; Luc Bidaut; Pierre Lane; J. Lou Benedet; Dianne Miller; Tom Ehlen; Roderick Price; Isaac F. Adewole; Calum MacAulay; Michele Follen

doi:10.1016/j.genm.2011.08.002

Optical technologies and molecular imaging for cervical neoplasia: A program project update

Timon P.H. Buys, Scott B. Cantor, Martial Guillaud, Karen Adler-Storthz, Dennis D. Cox, Clement Okolo, Oyedunni Arulogon, Oladimeji Oladepo, Karen Basen-Engquist, Eileen Shinn, Jos Miguel Yamal, J. Robert Beck, Michael E. Scheurer, Dirk Van Niekerk, Anais Malpica, Jasenka Matisic, Gregg Staerkel, Edward Neely Atkinson, Luc Bidaut, Pierre LaneJ. Lou Benedet, Dianne Miller, Tom Ehlen, Roderick Price, Isaac F. Adewole, Calum MacAulay, Michele Follen

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancerrelated deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institutefunded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.

Original language	English (US)
Pages (from-to)	S7-S24
Journal	Gender medicine
Volume	9
Issue number	1 SUPPL.
DOIs	https://doi.org/10.1016/j.genm.2011.08.002
State	Published - Feb 2012

Keywords

HPV
cervical cancer
human papillomavirus
screening

ASJC Scopus subject areas

Gender Studies

MD Anderson CCSG core facilities

Assessment, Intervention, and Measurement

Access to Document

10.1016/j.genm.2011.08.002

Cite this

Buys, T. P. H., Cantor, S. B., Guillaud, M., Adler-Storthz, K., Cox, D. D., Okolo, C., Arulogon, O., Oladepo, O., Basen-Engquist, K., Shinn, E., Yamal, J. M., Beck, J. R., Scheurer, M. E., Van Niekerk, D., Malpica, A., Matisic, J., Staerkel, G., Atkinson, E. N., Bidaut, L., ... Follen, M. (2012). Optical technologies and molecular imaging for cervical neoplasia: A program project update. Gender medicine, 9(1 SUPPL.), S7-S24. https://doi.org/10.1016/j.genm.2011.08.002

Buys, TPH, Cantor, SB, Guillaud, M, Adler-Storthz, K, Cox, DD, Okolo, C, Arulogon, O, Oladepo, O, Basen-Engquist, K , Shinn, E, Yamal, JM, Beck, JR, Scheurer, ME, Van Niekerk, D, Malpica, A, Matisic, J, Staerkel, G, Atkinson, EN, Bidaut, L, Lane, P, Benedet, JL, Miller, D, Ehlen, T, Price, R, Adewole, IF, MacAulay, C & Follen, M 2012, 'Optical technologies and molecular imaging for cervical neoplasia: A program project update', Gender medicine, vol. 9, no. 1 SUPPL., pp. S7-S24. https://doi.org/10.1016/j.genm.2011.08.002

@article{8505d73617354ed9b4c03b80c8abb427,

title = "Optical technologies and molecular imaging for cervical neoplasia: A program project update",

abstract = "There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancerrelated deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institutefunded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.",

keywords = "HPV, cervical cancer, human papillomavirus, screening",

author = "Buys, {Timon P.H.} and Cantor, {Scott B.} and Martial Guillaud and Karen Adler-Storthz and Cox, {Dennis D.} and Clement Okolo and Oyedunni Arulogon and Oladimeji Oladepo and Karen Basen-Engquist and Eileen Shinn and Yamal, {Jos Miguel} and Beck, {J. Robert} and Scheurer, {Michael E.} and {Van Niekerk}, Dirk and Anais Malpica and Jasenka Matisic and Gregg Staerkel and Atkinson, {Edward Neely} and Luc Bidaut and Pierre Lane and Benedet, {J. Lou} and Dianne Miller and Tom Ehlen and Roderick Price and Adewole, {Isaac F.} and Calum MacAulay and Michele Follen",

note = "Funding Information: The symposium and publication of these proceedings were supported by: The National Institutes of Health, The Drexel University College of Medicine, The Helen I. Moorehead, MD Foundation, The Doris Willig, MD Foundation, The Institute for Women{\textquoteright}s Health and Leadership, and The Center for Women{\textquoteright}s Health Research at the Drexel University College of Medicine. ",

year = "2012",

month = feb,

doi = "10.1016/j.genm.2011.08.002",

language = "English (US)",

volume = "9",

pages = "S7--S24",

journal = "Gender medicine",

issn = "1550-8579",

publisher = "Excerpta Medica",

number = "1 SUPPL.",

}

TY - JOUR

T1 - Optical technologies and molecular imaging for cervical neoplasia

T2 - A program project update

AU - Buys, Timon P.H.

AU - Cantor, Scott B.

AU - Guillaud, Martial

AU - Adler-Storthz, Karen

AU - Cox, Dennis D.

AU - Okolo, Clement

AU - Arulogon, Oyedunni

AU - Oladepo, Oladimeji

AU - Basen-Engquist, Karen

AU - Shinn, Eileen

AU - Yamal, Jos Miguel

AU - Beck, J. Robert

AU - Scheurer, Michael E.

AU - Van Niekerk, Dirk

AU - Malpica, Anais

AU - Matisic, Jasenka

AU - Staerkel, Gregg

AU - Atkinson, Edward Neely

AU - Bidaut, Luc

AU - Lane, Pierre

AU - Benedet, J. Lou

AU - Miller, Dianne

AU - Ehlen, Tom

AU - Price, Roderick

AU - Adewole, Isaac F.

AU - MacAulay, Calum

AU - Follen, Michele

N1 - Funding Information: The symposium and publication of these proceedings were supported by: The National Institutes of Health, The Drexel University College of Medicine, The Helen I. Moorehead, MD Foundation, The Doris Willig, MD Foundation, The Institute for Women’s Health and Leadership, and The Center for Women’s Health Research at the Drexel University College of Medicine.

PY - 2012/2

Y1 - 2012/2

N2 - There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancerrelated deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institutefunded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.

AB - There is an urgent global need for effective and affordable approaches to cervical cancer screening and diagnosis. In developing nations, cervical malignancies remain the leading cause of cancer-related deaths in women. This reality may be difficult to accept given that these deaths are largely preventable; where cervical screening programs have been implemented, cervical cancerrelated deaths have decreased dramatically. In developed countries, the challenges of cervical disease stem from high costs and overtreatment. The National Cancer Institutefunded Program Project is evaluating the applicability of optical technologies in cervical cancer. The mandate of the project is to create tools for disease detection and diagnosis that are inexpensive, require minimal expertise, are more accurate than existing modalities, and can be feasibly implemented in a variety of clinical settings. This article presents the status and long-term goals of the project.

KW - HPV

KW - cervical cancer

KW - human papillomavirus

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=84857370792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857370792&partnerID=8YFLogxK

U2 - 10.1016/j.genm.2011.08.002

DO - 10.1016/j.genm.2011.08.002

M3 - Article

C2 - 21944317

AN - SCOPUS:84857370792

SN - 1550-8579

VL - 9

SP - S7-S24

JO - Gender medicine

JF - Gender medicine

IS - 1 SUPPL.

ER -

Optical technologies and molecular imaging for cervical neoplasia: A program project update

Abstract

Keywords

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Fingerprint

Cite this